Cite
HARVARD Citation
Wang, Y. et al. (2022). Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T‐cell lymphoma in a Chinese population: A multicenter phase II trial. American journal of hematology. 97 (5), pp. 623-629. [Online].